Clinical trial
Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in…
NCT00199108 · Goethe University, Other · Completed
Key facts
| NCT number | NCT00199108 |
|---|---|
| Title | Treatment of Acute Lymphoblastic Leukemia or Aggressive Lymphoma With Relapse in Central Nervous System With Depocyt |
| Official title | A Phase-2 Clinical Study to Determine the Efficacy and Safety of Depocyt (Cytarabine Liposome Injection) for the Treatment of CNS Relapse in Adult Patients With Acute Lymphoblastic Leukemia or Very Aggressive Lymphoma |
| Lead sponsor | Goethe University, Other |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Adult Acute Lymphocytic Leukemia |
| Intervention type | Drug |
| Interventions | Depocyt, Dexamethasone |
| Enrollment | 20 |
| Start date | Apr 1, 2004 |
| Primary completion | Jun 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Sep 20, 2005 |
| Last update posted | Aug 18, 2022 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: